While the coronavirus pandemic has left the world bleeding, it has also highlighted weaknesses in the global healthcare systems that were hidden before. It is evident from the response to the pandemic that there was no plan in place on how to treat an unknown infectious disease like Covid_19. Despite the challenges that the world is facing, there is hope in big data and big data analytics. Big data has changed how data management and analysis is carried out in healthcare. Healthcare data analytics is capable of reducing the costs of treatment and can also help in the prediction of epidemics’ outbreak, prevent diseases, and enhance the quality of life.

Frost & Sullivan’s recent analysis, Post-pandemic Growth Opportunity Analysis of the Big Data Analytics Market, predicts that the global Big Data Analytics (BDA) market is estimated to witness double-digit growth in the post-pandemic COVID-19 era. Under an aspirational forecast scenario, which assumes that the COVID-19 virus is contained by August 2020 and that global markets will be able to recover by the end of the year, the market is expected to expand at a compound annual growth rate (CAGR) of 28.9%, reaching $68.09 billion by 2025 from $14.85 billion in 2019. Under the conservative forecast scenario, the market is likely to reach $41.84 billion by 2025, at a CAGR of 18.8%. Depending on the development and availability of a vaccine, the conservative forecast includes a market slowdown and recovery period of 18 to 24 months.

In the modern world characterized by connectivity and different devices, making intelligent use of big data is turning out to be a breakthrough for many industries. With the increasing damage meted on humanity and economy by COVID-19, the need to have access to big data and technology in general due to social distancing and lockdown has changed many things in different industries. With the changes, some of which may appear temporary but will be permanent going into the future, a company that manages to utilize data will rule.